The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
TAKE HEART MTK we're probably still a couple of days away and there are plenty of nervous PI's who were expecting today would be a news day. If someone had told me a month ago my AEX would be outperforming CHAR and ZPHR I would have laughed but today totally unexpectedly they have. Not long to wait now!
Laura I have leant that its best to exercise patience with the Board of PYC . On matters pertaining to ValaiRx I was extremely unhappy years ago that Gene Ice was transferred away from PYC as I believed at the time it was an very important holding in the PYC portfolio and an excellent fit. That said I won't hold my breath on 201 its just a bonus if it happens. We tried to buy ValiRx when it was worth nothing a few years ago but were thwarted in our attempts though provided enough incite to others that was sufficient to enable its steady progress on the market and fundability. I did say that I was not surprised that Board members were not buying They currently receive a lot less in comparison to AIM directors generally and haven't awarded themselves bucket loads of options either. I think we will soon get notification of both contract sign offs, an update on the new BioStats Division and quite possibly an indication of successful outcomes from the conferences. As I have said previously PYC are in the right space at the right time Lets give PS a chance to prove himself rather than second guess, as at least one negative poster is hell bent on doing. News will soon propel the share price as with all AIM stocks and we are very undervalued irrespective recent announcements by the company. I am more than happy to defend their position and the Company's future which in my opinion if bright.
I agree Adon best outfit in the world to doing the drilling. Might see a few people loading up now or closing shorts, success will be a game changer. Long overdue! Thursday or Friday we should have a clearer picture.
Goonerpete where would we be without a little controversial excitement in our lives. I was pleased with Clon today and still am even though its come off its highs for the day. As you get older you you do appreciate the AAL's and RR.'s of this world but they will never give the same satisfaction as when the small caps get it right. I detect a note of despondency chin up its still all to play for. I'll wait for the rebound which from 6.22 is occurring and look forward to ZPHR taming the monster they are drilling into and AEX signing off their licence...the latter is 8 trillion cubic feet already to go.
Goonerpete Off shore is key and the rest of the portfolio If the next onshore drill is successful today will be forgotten. When offshore drilling campaign starts it will be a thing of the past. They have multiple zones to explore you cant win them all.
Hi Goonerpete I thought today was looking good at first...ZPHR/ AEX and CHAR all up but never seem to get all the ducks in a row Nevermind "2 out of 3 aint bad" as they say and this will soon rebound have no fear.
Goonerpete don,t worry even a dog has its day. MM's making a bob or two as usual. As I said before ride the storm its nothing we haven't seen before The fundamentals are still good and this was only an exploratory bonus.
I am have been holding since 1.55p and have added some more this afternoon. It was Bubbles that caused the problem., and it is only one drill. Off shore Char has Trillions of Cubic Feet and a partner to exploit it.
Dear I say this is an excellently worded RNS. Its informative and explains the best possible route to funding. The EU must be aware that if the majority of this resource were to be awarded to China it could prove to be a massive step to far. China and Russia speak as one at present and Chinese control could present them with far greater problems than EU economies could afford.
Avery underestimated vegetable as is this share perhaps
Trench with respect now is not the time . They have responses and feed back from 2 conferences that no doubt they will be addressing and are working on signing off two contracts that will form a major element / backbone of next years trading. There after we should receive more information on their pipeline. I know its a far better feeling to see the share price moving up but as others have said a little patience is required at moment and I totally agree. My average is approximately 1.38 and I am happy to continue buying sub 2p on information currently to hand. Once they publish news of progress I will re-evaluate this. As I have said previously the opportunities are out there and PYC is well placed to address them.
I agree with you but you must remember that some of us have been invested for over 20 years. The FDA's requirements for insilico prediction are very welcome but the company does need to pursue its objectives and advantage itself of their Act ( Dec 22 ). and not let the grass grow under its feet. We have all acknowledged that personalised medicine is the way forward and that the company is in a position at long last to realise its potential . Time is actually of the essence in this respect PYC needs to ensure that its sales techniques are in line with current thought, the time to sit back and relax are long gone. Critically if the board cannot sell their technology they need someone that can! I am so supportive but need to see action not talk or intellectual debate. I am buying and will continue to do so but shareholders need action to ensure their faith is justified! ! There are a lot of M&A opportunities out there and similarly royalty shares for service PYC need to be flexible and innovative!!